These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 29414290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
    Sugijono SE, Mulyadi R, Firdausia S, Prihartono J, Estiasari R.
    Neurosciences (Riyadh); 2020 Jul; 25(3):193-199. PubMed ID: 32683399
    [Abstract] [Full Text] [Related]

  • 3. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
    Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M.
    J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
    [Abstract] [Full Text] [Related]

  • 4. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis.
    Cassiano MT, Lanzillo R, Alfano B, Costabile T, Comerci M, Prinster A, Moccia M, Megna R, Morra VB, Quarantelli M, Brunetti A.
    Neuroimage Clin; 2020 Feb; 26():102201. PubMed ID: 32062567
    [Abstract] [Full Text] [Related]

  • 5. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M, Koikkalainen J, Lötjönen J, Selander T, Cajanus A, Hartikainen P, Simula S, Vanninen R, Remes AM.
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [Abstract] [Full Text] [Related]

  • 6. Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.
    Kalinowska-Lyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Bus K, Leszczynski P, Puszczewicz M, Paprzycki W, Kozubski W, Michalak S.
    Lupus; 2018 Sep; 27(10):1624-1635. PubMed ID: 29950159
    [Abstract] [Full Text] [Related]

  • 7. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M, Lotze M, Langner S, Dressel A.
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [Abstract] [Full Text] [Related]

  • 8. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC, Pagani E, Rodegher M, Colombo B, Preziosa P, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal changes of deep gray matter shape in multiple sclerosis.
    Tsagkas C, Geiter E, Gaetano L, Naegelin Y, Amann M, Parmar K, Papadopoulou A, Wuerfel J, Kappos L, Sprenger T, Granziera C, Mallar Chakravarty M, Magon S.
    Neuroimage Clin; 2022 Feb; 35():103137. PubMed ID: 36002960
    [Abstract] [Full Text] [Related]

  • 10. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X, Zhu Q, Yan Z, Shi Z, Xu Y, Liu Y, Li Y.
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [Abstract] [Full Text] [Related]

  • 11. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T, Bergendal G, Shams S, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S, Martola J.
    J Neuroimaging; 2015 Jul; 25(6):996-1001. PubMed ID: 25786805
    [Abstract] [Full Text] [Related]

  • 12. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S, Seddigh A, Combes A, Russell-Schulz B, Tam R, Yogendrakumar V, Deoni S, Sibtain NA, Traboulsee A, Williams SC, Barker GJ, Brex PA.
    Neuroimage Clin; 2015 Jul; 9():574-80. PubMed ID: 26594633
    [Abstract] [Full Text] [Related]

  • 13. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J, Yablonskiy DA, Luo J, Lancia S, Hildebolt C, Cross AH.
    Neuroimage Clin; 2015 Jul; 9():164-75. PubMed ID: 27330979
    [Abstract] [Full Text] [Related]

  • 14. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

  • 15. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [Abstract] [Full Text] [Related]

  • 16. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

  • 17. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Buś K, Leszczyński P, Puszczewicz M, Majewski D, Paprzycki W, Kozubski W, Michalak S.
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [Abstract] [Full Text] [Related]

  • 18. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG.
    Brain; 2018 Sep 01; 141(9):2605-2618. PubMed ID: 30169585
    [Abstract] [Full Text] [Related]

  • 19. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
    MacKenzie-Graham A, Kurth F, Itoh Y, Wang HJ, Montag MJ, Elashoff R, Voskuhl RR.
    JAMA Neurol; 2016 Aug 01; 73(8):944-53. PubMed ID: 27294295
    [Abstract] [Full Text] [Related]

  • 20. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
    Damjanovic D, Valsasina P, Rocca MA, Stromillo ML, Gallo A, Enzinger C, Hulst HE, Rovira A, Muhlert N, De Stefano N, Bisecco A, Fazekas F, Arévalo MJ, Yousry TA, Filippi M.
    AJNR Am J Neuroradiol; 2017 Jan 01; 38(1):18-24. PubMed ID: 27686487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.